Every ingredient amount is disclosed
The panel gives a per-ingredient amount rather than hiding quantities inside a proprietary blend, so each one can be compared to published research.
Full record · 853913003497 · back to the summary

Free to read, download and share — no signup, no paywall, no ads.
What this is. We compare what a listing claims against what public records show — label arithmetic, barcode registries, NIH’s label catalog, FDA enforcement data, certification registries, and published research. Every statement below traces to one of those.
What the states mean. Confirmed = an outside source agrees. Contradicted = an outside source disagrees. Caution = something needs explaining. No data = we looked and found nothing — a gap, not a strike.
What it is not. A clean record is not an endorsement and never proof a product works. A thin record is not an accusation. We publish evidence and gaps; the conclusion is yours. Nothing here is medical advice.
Something wrong? Every figure is meant to be checkable — sources are named and linked. Send a correction and we’ll fix the record.
We did the comparison: the listing claims 150 mg of nmn (β-nicotinamide mononucleotide), and the listing-image panel shows 150 mg nmn (β-nicotinamide mononucleotide) 1 capsule. Those amounts agree. This is internal consistency, not independent lab testing.
| Panel row | Amount | %DV | What to notice |
|---|---|---|---|
| NMN (β-Nicotinamide Mononucleotide) | 150 mg | — |
FDA rules (21 CFR 101.36) require the amount of each dietary ingredient per serving unless hidden in a listed “proprietary blend” (legal, but a transparency yellow flag). A label stating no amount at all is non-compliant — a checkable red flag. This panel states amounts; any remaining comparison concerns the front-label framing.
vision:claude-cli:subscription Amounts are shown as listed panel data, not independently lab-tested contents.
Every check we ran
Confirmed evidence
These checks found support in the public record. They confirm specific facts, not the product as a whole.
The panel gives a per-ingredient amount rather than hiding quantities inside a proprietary blend, so each one can be compared to published research.
Documented concerns
These are documented contradictions or claims that need more evidence. They are separate from missing data.
label claims 150 mg/serving — below the range commonly used in research (human trials to date mostly use 250–1,000 mg/day). A lower dose is not necessarily useless — but it is not the amount the research used. Sources: PubMed search: nicotinamide mononucleotide human trial, ClinicalTrials.gov — NMN.
Unresolved public record
We looked for these signals but could not settle them from public sources. A gap is not a strike.
Marketplace rating not shown★ — rating count unavailable. No exact-listing count history was available, so no review-pattern claim is made.
USPTO returned multiple live supplement-class records for the exact brand wordmark: General Nutrition Investment Company, GNC Holdings, LLC. These records answer who owns registrations for the brand; the separate product-to-owner or manufacturer link remains open.
The listing claims 150 mg; the photo-read Supplement Facts panel shows NMN (β-Nicotinamide Mononucleotide) at 150 mg per serving — the listing text and its photo-read panel agree; this is internal consistency, not independent testing.
At 1.7 serving(s) a day to reach the low end of the studied range (250–1000 mg), this product runs roughly $39 per month. A price observation, not a recommendation.
Published sources describe how NMN have been studied. This is ingredient context only; the record does not establish that this product delivers the studied dose or outcome. Sources: PubMed search: nicotinamide mononucleotide human trial, ClinicalTrials.gov — NMN.
This recall is not about the product on this page. GNC Holdings LLC recalled a different product on April 25, 2025. FDA has since closed that case. The recalled item was “GNC Women's 30+ Vitapak, Carton of 30 Sachets. Each sachet contains four tablets and a capsule. Paper-board carton that measures 10.25 width x 3.56 height x 3.15 depth containi”. FDA recorded the reason as “Undeclared Fish allergen (parvalbumin)”. Verify at FDA’s recall database.
We have not found a public label filing for this exact product. That is a gap in our records, not evidence that no filing exists.
Open Food Facts resolves 853913003497 to "nad NMN" (141604), but that record lacks enough exact brand/product detail to confirm or contradict this listing.
What to ask and check
Ask the brand or seller
Answered by the panel: 0.15 g of the 0.15 g headline is nmn. Which independent lab can confirm that amount in this product?
The panel resolves the front-label arithmetic. The remaining question is lot-specific contents and stability; published category testing gives context, not a test of this product.
Is this label filed with NIH’s Dietary Supplement Label Database (DSLD)?
Filing is voluntary, so absence proves nothing — but a filed label puts the full ingredient table on public record where anyone can read it.
Why is the NMN (nicotinamide mononucleotide) amount below the dose used in published research?
There can be good answers — a more bioavailable form, a different intended use. Ask for the reasoning and any data behind it.
Most brands and sellers publish a contact route. A clear answer adds evidence to the record; no answer leaves the question open.
Check for yourself — no one’s permission needed
Compare the panel on the bottle in your hand to the one shown in this record.
Ours was read from listing photos and can contain reading errors. The physical label is the source of truth — if they disagree, tell us and we’ll correct the record.
Scan the barcode on the package and confirm it reads 853913003497.
A mismatch between the barcode on the box and the one on the listing is worth pausing over — it can indicate a different variant, a repack, or a counterfeit.
Check the lot number and expiry on the bottle against any COA you’re given.
A certificate that doesn’t name your lot doesn’t describe what you’re holding.
These are the open questions on this specific record — not a warning about the product, and not a suggestion to buy or avoid it. Getting them answered is how you decide for yourself.
What the listing promises — claim by claim
| Claim | Status | What we found |
|---|---|---|
| Benefit claim “…NAD Precursor: NMN produces NAD+, which supports healthy DNA*…” | Partly supported We looked for: whether the ingredient doses on the label match the doses used in published research | Ingredient evidence exists; on dose: label claims 150 mg/serving — below the range commonly used in research (human trials to date mostly use 250–1,000 mg/day). |
“No evidence located” does not mean a claim is false — it means the seller has not put evidence proportionate to the claim on the public record, and we could not find any. Absence of proof is not proof of absence.
This label vs. the doses studied
| Ingredient | Where this label sits | Reading |
|---|---|---|
| NMN (β-Nicotinamide Mononucleotide) | shaded = doses used in studies (250 mg–1 g) · bar = this label | 150 mg — below the studied range |
Matching a studied dose does not mean the product works, and missing it does not mean it fails — it shows whether the label and the research are talking about the same amounts. Not a recommendation to take any amount.
Verifiability profile — 4 of 6 public signals
What this listing gives the public to check. Publishing these signals doesn't prove quality — but withholding them means claims can only be taken on faith.
Identity
| UPC (barcode) — also our record ID | 853913003497 — via source listing UPC |
| Brand | GNC |
| Source listing identifier | B0FW6G4DDT |
| Retailer listing title | GNC Preventive Nutrition NMN, NMN Supplement, 60 Count, 60 Servings… show full titleGNC Preventive Nutrition NMN, NMN Supplement, 60 Count, 60 Servings |
| USPTO brand-owner record | General Nutrition Investment Company · ARIZONA, USA · registration 3429065 · 1011 Centre Road - Suite 322, Wilmington, DELAWARE 19805, UNITED STATES |
| USPTO brand-owner record | General Nutrition Investment Company · DELAWARE, USA; ARIZONA, USA · registration 2180647 · 103 Springer Building, 3411 Silverside Road, Wilmington, DELAWARE 19810, UNITED STATES |
| USPTO brand-owner record | GNC Holdings, LLC · Delaware, USA · registration 7612523 · 75 Hopper Place - Suite 501, Pittsburgh, Pennsylvania 15222, UNITED STATES |
From the label (photo-read)
| Serving size | 1 Capsule |
| Pack statement | 60 CAPSULES |
| Badges printed on pack | SCIENTIFICALLY FORMULATED, Gluten Free |
Supplement Facts panel (photo-read):
| Ingredient | Amount per serving | Reading confidence |
|---|---|---|
| NMN (β-Nicotinamide Mononucleotide) | 150 mg | High clearly legible in the photo |
Claims printed on the packaging:
“Contains 150 mg NMN Per Capsule” · “Supports production of NAD+, which helps with DNA repair*” · “NMN can be naturally converted to NAD+ in the body*” · “DIETARY SUPPLEMENT” · “60-DAY SUPPLY” · “Enhance Building Blocks of Wellness” · “GNC Preventive Nutrition® NMN can supply your body with raw material to support healthy NAD+ levels*” · “NMN Boosts NAD+ Levels More Than NAD+ Alone”
Read by a vision model from 7 listing photos — verbatim extraction; OCR errors possible. Spot a mistake? It will be corrected on review.
Where it sells
| Seller | Price |
|---|---|
| Retailer listing ↗ | $46.99 checked Aug 02, 2026 — varies by variant/session; price history pending |
Official brand domain: www.gnc.com. This storefront does not expose a complete public catalog count.
Reference links for identification only — LookCloser has no affiliate relationships and earns nothing from any link on this page.
Related research & consistency
NMN (nicotinamide mononucleotide) — PubMed search: nicotinamide mononucleotide human trial · ClinicalTrials.gov — NMN · ClinicalTrials.gov — 39 registered studies
ℹ Dosage: label claims 150 mg/serving — below the range commonly used in research (human trials to date mostly use 250–1,000 mg/day).
ℹ Use pattern in research: trials report raised NAD+ blood markers; whether that produces anti-aging or energy outcomes people care about remains unsettled in humans.
These notes state where label numbers and marketing framing sit relative to published research — documentation for your own judgment, not medical advice. LookCloser does not advise for or against taking any supplement.
Record 853913003497 · built August 02, 2026 · lookcloser.ai · corrections@lookcloser.ai